التفاصيل البيبلوغرافية
العنوان:
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
المؤلفون:
Giovanni Palladini , Ute Hegenbart , Marta Vidus Rosin , Giampaolo Merlini , Christoph Kimmich , Remigio Moratti , Riccardo Albertini , Paolo Milani , Andrea Foli , Anthony D. Ho , Stefan Schönland
المصدر:
Blood . 124(15)
سنة النشر:
2014
مصطلحات موضوعية:
Male , medicine.medical_specialty , Pathology , Time Factors , medicine.medical_treatment , Immunology , Urology , Renal function , urologic and male genital diseases , Kidney , Biochemistry , Cohort Studies , Risk Factors , AL amyloidosis , Medicine , Humans , Immunoglobulin Light-chain Amyloidosis , Dialysis , Survival analysis , Aged , Proportional Hazards Models , Proteinuria , business.industry , Amyloidosis , Reproducibility of Results , Cell Biology , Hematology , Middle Aged , medicine.disease , Survival Analysis , medicine.anatomical_structure , Treatment Outcome , Disease Progression , Female , Immunoglobulin Light Chains , Hemodialysis , medicine.symptom , business , Biomarkers
الوصف:
The kidney is involved in 70% of patients with immunoglobulin light-chain (AL) amyloidosis, but little is known on progression or reversibility of renal involvement, and criteria for renal response have never been validated. Newly diagnosed patients from the Pavia (n = 461, testing cohort) and Heidelberg (n = 271, validation cohort) centers were included. Proteinuria >5 g/24 h and estimated glomerular filtration rate (eGFR)
تدمد:
1528-0020
URL الوصول:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0451b8b21ccef6b393abb22b2b9aa36 https://pubmed.ncbi.nlm.nih.gov/25301329
رقم الأكسشن:
edsair.doi.dedup.....c0451b8b21ccef6b393abb22b2b9aa36
قاعدة البيانات:
OpenAIRE
